TSS
CTXR icon

Two Sigma Securities’s Citius Pharmaceuticals CTXR Stock Holding History

Two Sigma Securities’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,578
Closed -$22.2K – 1744
2025
Q4 		$22.2K Buy
+28,578
New +$35.7K ﹤0.01% 1164
2024
Q1 		– Sell
-1,262
Closed -$23.9K – 3072
2023
Q4 		$23.9K Buy
1,262
+801
+174% +$15.2K ﹤0.01% 2695
2023
Q3 		$7.88K Sell
461
-105
-19% -$2.5K ﹤0.01% 2735
2023
Q2 		$17K Buy
+566
New +$18.6K ﹤0.01% 2531
2023
Q1 		– Sell
-2,465
Closed -$48.7K – 2770
2022
Q4 		$48.7K Buy
2,465
+603
+32% +$16.5K ﹤0.01% 2167
2022
Q3 		$56K Buy
+1,862
New +$51.2K ﹤0.01% 2173
2021
Q1 		– Sell
-822
Closed -$21K – 1013
2020
Q4 		$21K Buy
+822
New +$21.4K ﹤0.01% 1601
2020
Q3 		– Sell
-418
Closed -$12K – 1358
2020
Q2 		$12K Buy
+418
New +$9.14K ﹤0.01% 1306

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Two Sigma Securities's CTXR Position: Q1 2026 in Review

Two Sigma Securities sold out of Citius Pharmaceuticals (CTXR) in Q1 2026, closing a stake of 28,578 shares — an estimated $22.2K sold.

Two Sigma Securities first reported a position in CTXR in Q2 2020 and held it in 8 quarters. The position peaked at $56K in Q3 2022. 38 funds tracked by Wall St. Rank hold CTXR as of Q1 2026.

  • Two Sigma Securities reported no remaining Citius Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 28,578 Citius Pharmaceuticals shares in Q1 2026, an estimated $22.2K.
  • Two Sigma Securities first reported a position in Citius Pharmaceuticals in Q2 2020 and held it in 8 quarters.
  • Two Sigma Securities's Citius Pharmaceuticals position peaked at $56K in Q3 2022.
  • 38 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.